Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Biomed Research International
|
June 29, 2017
TDF Monotherapy Is Effective Regardless of Prior Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patients in China
Mingxing Huang, Guoli Lin, Hong Shi, et al.
Hepatology International
|
July 24, 2015
Real-life practice of antiviral therapy and disease patterns of patients with chronic hepatitis B: a single-center retrospective observation study
Yusheng Jie, Xiangyong Li, Guoli Lin, et al.
International Immunopharmacology
|
September 20, 2025
TRIM21 exacerbates hypoxia-induced cardiomyocyte Pyroptosis through GSDMD ubiquitination in post-myocardial infarction heart failure
Guoli Lin, Juying Li, Yihao Huang, et al.
International Journal of Clinical and Experimental Medicine
|
March 19, 2015
Comparison of the efficacy of tenofovir disoproxil fumarate and entecavir for initial treatment of patient with chronic hepatitis B in China
Mingxing Huang, Yusheng Jie, Hong Shi, et al.
Clinical Drug Investigation
|
March 20, 2016
Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B Patients
Mingxing Huang, Yusheng Jie, Guoli Lin, et al.
Plos One
|
June 2, 2017
Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis
Zhanyi Li, Bingliang Lin, Guoli Lin, et al.
Biomed Research International
|
August 29, 2020
Prediction Model of HBsAg Seroclearance in Patients with Chronic HBV Infection
Jing Cao, Jiao Gong, Christ-Jonathan Tsia Hin Fong, et al.
Annals of Palliative Medicine
|
December 24, 2019
Barriers to hepatitis C virus treatment in Guangdong Province
Xiaohua Yang, Zhen Xu, Yongyu Mei, et al.
Biomed Research International
|
November 23, 2017
Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients
Zhanyi Li, Ying Liu, Ying Zhang, et al.
International Journal of Clinical and Experimental Medicine
|
February 18, 2016
Optimized combination therapies with adefovir dipivoxil (ADV) and lamivudine, telbivudine, or entecavir may be effective for chronic hepatitis B patients with a suboptimal response to ADV monotherapy
Xiangyong Li, Yusheng Jie, Xu You, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Biomed Research International
|
June 29, 2017
TDF Monotherapy Is Effective Regardless of Prior Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patients in China
Mingxing Huang, Guoli Lin, Hong Shi, et al.
Hepatology International
|
July 24, 2015
Real-life practice of antiviral therapy and disease patterns of patients with chronic hepatitis B: a single-center retrospective observation study
Yusheng Jie, Xiangyong Li, Guoli Lin, et al.
International Immunopharmacology
|
September 20, 2025
TRIM21 exacerbates hypoxia-induced cardiomyocyte Pyroptosis through GSDMD ubiquitination in post-myocardial infarction heart failure
Guoli Lin, Juying Li, Yihao Huang, et al.
International Journal of Clinical and Experimental Medicine
|
March 19, 2015
Comparison of the efficacy of tenofovir disoproxil fumarate and entecavir for initial treatment of patient with chronic hepatitis B in China
Mingxing Huang, Yusheng Jie, Hong Shi, et al.
Clinical Drug Investigation
|
March 20, 2016
Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B Patients
Mingxing Huang, Yusheng Jie, Guoli Lin, et al.
Plos One
|
June 2, 2017
Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis
Zhanyi Li, Bingliang Lin, Guoli Lin, et al.
Biomed Research International
|
August 29, 2020
Prediction Model of HBsAg Seroclearance in Patients with Chronic HBV Infection
Jing Cao, Jiao Gong, Christ-Jonathan Tsia Hin Fong, et al.
Annals of Palliative Medicine
|
December 24, 2019
Barriers to hepatitis C virus treatment in Guangdong Province
Xiaohua Yang, Zhen Xu, Yongyu Mei, et al.
Biomed Research International
|
November 23, 2017
Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients
Zhanyi Li, Ying Liu, Ying Zhang, et al.
International Journal of Clinical and Experimental Medicine
|
February 18, 2016
Optimized combination therapies with adefovir dipivoxil (ADV) and lamivudine, telbivudine, or entecavir may be effective for chronic hepatitis B patients with a suboptimal response to ADV monotherapy
Xiangyong Li, Yusheng Jie, Xu You, et al.
Page
of 3